| Literature DB >> 34201944 |
Chenhao Hu1, Yueyuan Yu1, Shuang Chao1, Huidan Zhu2, Yuxin Pei1, Lan Chen2, Zhichao Pei1.
Abstract
Photodynamic therapy (PDT) as a safe, non-invasive modality for cancer therapy, in which the low oxygen and high glutathione in the tumor microenvironment reduces therapeutic efficiency. In order to overcome these problems, we prepared a supramolecular photosensitive system of O2-Cu/ZIF-8@ZIF-8@WP6-MB (OCZWM), which was loaded with oxygen to increase the oxygen concentration in the tumor microenvironment, and the Cu2+ in the system reacted with glutathione (GSH) to reduce the GSH concentration to generate Cu+. It is worth noting that the generated Cu+ can produce the Fenton reaction, thus realizing the combination therapy of PDT and chemodynamic therapy (CDT) to achieve the purpose of significantly improving the anti-cancer efficiency.Entities:
Keywords: CDT; PDT; combination therapy; host–guest complexation; pillar[6]arene
Mesh:
Substances:
Year: 2021 PMID: 34201944 PMCID: PMC8271439 DOI: 10.3390/molecules26133878
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Schematic of the construction of supramolecular photosensitizer system based on nano-Cu/ZIF-8@ZIF-8 capped with the host–guest complexation between WP6–MB.
Figure 1TEM images of (a) Cu/ZIF-8@ZIF-8 and (b) Cu/ZIF-8@ZIF-8@WP6–MB. The scale bar is 200 nm. Inset: partial enlarged images. The scale bar is 200 nm. (c) DLS data of Cu/ZIF-8@ZIF-8@WP6–MB. (d) UV-Vis spectra of Cu/ZIF-8@ZIF-8@WP6–MB and MB aqueous solution at room temperature.
Figure 2(a) the O2 content under the solution of OCZWM in pH = 6.5 and pH = 7.4. (b) The amount of ROS produced by OCZWM in pH = 6.5 and pH = 7.4. (c) The GSH content under the solution of OCZWM in pH = 6.5 and pH = 7.4.
Figure 3CLSM of HepG2 cells incubated with OCZWM (a) and Cu/ZIF-8@ZIF-8@WP6–MB (b). The scale bar is 50 µm. (b) the GSH content under the OCZWM, Cu/ZIF-8@ZIF-8@WP6–MB, MB, control.
Figure 4Relative cell viability of (a) HL7702 cells and (b) HepG2 cells after treatment with OCZWM, Cu/ZIF-8@ZIF-8@WP6–MB at different concentrations. (c) Relative cell viability of HepG2 cells after treatment with OCZWM, WP6–MB at different concentrations.